AK

Anil Kumar

Active Director Director DIN 09309730
DIN 09309730 First appointment Sep 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value •••• Premium profile

About Anil Kumar

Data last updated:

Anil Kumar is a Director at Navian Pharma Private Limited (since 2021). The company operates in Chemicals. Navian Pharma Private Limited reported revenue of ₹70.1 Lakh (FY 2025).

DIN 09309730
Primary Designation Director
Industry Chemicals
First Appointment 07 Sep 2021
Oldest Company Age 5 yrs
Largest company Navian Pharma Private Limited · ₹70.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Navian Pharma Private Limited U24100MP2021PTC057379
Director07 Sep 20212021₹70.1 Lakh (FY 2025)Active

Board colleagues of Anil Kumar

NameDINCompanyDesignation
Priyanka Pal08975255Navian Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Navian Pharma Private Limited
Premium access

Shareholding and investment profile for Anil Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anil Kumar

Anil Kumar currently holds 1 directorship: Navian Pharma Private Limited (Director, since 07 Sep 2021, revenue ₹70.1 Lakh (FY 2025)).

Anil Kumar was first appointed on 07 Sep 2021 as Director at Navian Pharma Private Limited.

The current boards of Anil Kumar's companies include Priyanka Pal (Navian Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available